Blockade of the Ras/PI3K/Akt pathways reduced the expression of TGF-β as an angiogenic factor in mouse osteosarcoma [51] and suppressed TGF-β1 production by macrophages treated with phophatidylserine-liposomes [52]. The gene discussed is TGFB1; the disease is osteosarcoma.